The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Pavulon
Synonyms :
pancuronium
Class :
Neuromuscular Blockers, Nondepolarizing
Brand Name :
Pavulon
Synonyms :
pancuronium
Class :
Neuromuscular Blockers, Nondepolarizing
Dosage forms & Strengths:Â
Injectable solution:Â
1 mg/mlÂ
2 mg/mlÂ
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may increase the neuromuscular effect of corticosteroids
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Inhalational Anesthetics
neomycin/polymyxin B/gramicidin ophthalmicÂ
may increase the neuromuscular-blocking effect of Polymyxin B
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
aluminum hydroxide/magnesium hydroxideÂ
may increase the neuromuscular-blocking effect of magnesium Salts
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic drugs
anticholinergic agents increase the effect of cimetropium
it increases the effect of constipation of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of ulcer formation of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
anticholinergic agents increase the effect of tiotropium
may diminish the rate of excretion which results in higher serum level
may diminish the rate of excretion which results in higher serum level
may diminish the rate of excretion which results in higher serum level
may diminish the rate of excretion which results in higher serum level
may diminish the rate of excretion which results in higher serum level
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the therapeutic effect
may increase the tachycardic effect
may increase the tachycardic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
vancomycin may enhance the effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agentsÂ
may diminish the neuromuscular-blocking effect of neuromuscular blocking agentsÂ
may diminish the neuromuscular-blocking effect of neuromuscular blocking agentsÂ
methyldopa/hydrochlorothiazideÂ
may increase the neuromuscular blocking effect of thiazide and thiazide like diuretics
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the cholinergic effect of cholinergic agents
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular blocking effect of magnesium salts
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the risk of adverse effect of other cholinergic antagonistsÂ
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may diminish the serum concentration when combined with neuromuscular-blocking agents
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
bismuth subcitrate, metronidazole and tetracycline
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
bismuth subcitrate, metronidazole and tetracycline
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
may reduce the therapeutic effect of secretin
may decrease the neuromuscular-blocking effect when combined
local anesthetics increase the efficacy of neuromuscular blockers
may increases the neuromuscular-blocking effect of Magnesium Salts
may increase the neuromuscular-blocking effect of Magnesium Salts
may have an increased therapeutic effect when combined with neuromuscular blocking drugs
neomycin/polymyxin B/bacitracin topical
may have an increased therapeutic effect when combined with neuromuscular blocking drugs
anticholinergic agents increase the toxic or adverse effects of topiramate
it increases the effect of anticholinergic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
anticholinergic agents increase the effect of cannabinoid products
anticholinergic agents increase the effect of cannabinoid products
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
lansoprazole, amoxicillin, and clarithromycin
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
benzoyl peroxide, clindamycin phosphate, adapaleneÂ
caution is recommended when using this medication in patients using other neuromuscular blocking agents, as the clindamycin in this medication enhances the neuromuscular blocking properties of other neuromuscular agents
may increase the respiratory depressant effect
due to the anticholinergic activity of diphenhydramine, the effects of anticholinergics (e.g., some psychotropic drugs and atropine) may be intensified, leading to symptoms such as dry mouth, gastrointestinal disturbances (e.g., colic), urinary retention, increased heart rate, and headache
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
may diminish the effects of pharmacodynamic antagonism
anticholinergic agents increase the constipating effect of clozapine
Frequency undefined:Â
Excessive salivationÂ
Dose-related tachycardiaÂ
WheezingÂ
Transient rashesÂ
Elevation of BPÂ
Histamine releaseÂ
Pancuronium is contraindicated in patients hypersensitive to the active ingredient.Â
Pregnancy consideration:Â Â
Category CÂ
Breastfeeding warnings:Â Â
No data is available regarding the excretion of the drug in breast milk.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: pancuroniumÂ
Pronounced: pan-kyu-ro-ni-umÂ
Why do we use pancuronium?Â
Pancuronium is a neuromuscular blocker. It is used for endotracheal intubation and as general anesthesia.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
